Discovery on Target 2020

AbCellera's co-founder and Head of Business Development, Kevin Heyries, Ph.D., will be presenting 'Amplifying antibody diversity with Single-cell screening and immune repertoire sequencing'. High throughput single-cell screening is enabling the rapid generation of large, diverse antibody sequence datasets. By combining immune repertoire sequencing with functionally validated single-cell data, we further expand antibody diversity accessible for lead identification. Celium™, AbCellera's interactive software, interprets these complex datasets using dynamic visual networks to guide the selection of valuable antibodies. This unparalleled ability to both generate and visualize highly curated large datasets dramatically expands the pool of potential therapeutic candidates.